Skip to content

Study for neuroimaging of regulating DMN of insomnia patients by Tiaoshen acupuncture therapy

Study for neuroimaging of regulating DMN of insomnia patients by Tiaoshen acupuncture therapy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005529
Enrollment
Unknown
Registered
2022-01-11
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

2:acupuncture

Sponsors

Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Meeting the above diagnostic criteria of insomnia disorder. 2 Aged 20–60 years. 3 Pittsburgh Sleepiness Scale (PSQI) score > 8. 4 Hamilton Depression Rating Scale (HAMD)score 32. 7 Informed consent signed by the subject themself or an immediate family member. 8 Not taking anti-anxiety, anti-depressant, or sleep medications in the past month 9 No acupuncture treatment for insomnia in recent 1 month 10 Right handed

Exclusion criteria

Exclusion criteria: 1, Depression, anxiety, schizophrenia, or other serious mental illnesses. 2. Severe heart, brain, kidney, or liver disease. 3. Alcohol or drug dependence 4.Failure to cooperate with examination and treatment. 5. Apnea or restless leg syndrome. 6. Pregnant and lactating women. 7. Claustrophobia or other contraindications to MRI examination. 8. A definite lesion on MRI or grossly asymmetrical anatomy of the head

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleepiness Scale (PSQI) score;

Secondary

MeasureTime frame
Fatigue Scale-14,FS-14;Hamilton depression scale, HAMD;rs-fMRI;Hyperarousal scale,HAS;ActiGraph;Insomnia Severity Index, ISI;Montreal cognitive assessment, MoCA;Hamilton anxiety scale, HAMA;

Countries

China

Contacts

Public ContactJing Guo
guojing_2002@163.com87906910

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026